​

Entera Bio (ENTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Entera Bio Revenue Highlights

Latest Revenue (Y)

$181.00K

0

Entera Bio Revenue by Period

Entera Bio Revenue by Year

DateRevenueChange
2024-12-31$181.00K100.00%
2023-12-31--100.00%
2022-12-31$134.00K-76.53%
2021-12-31$571.00K56.44%
2020-12-31$365.00K54.66%
2019-12-31$236.00K-52.80%
2018-12-31$500.00K100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Entera Bio generated $181.00K in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 76.69% compared to the same period a year ago.

Entera Bio Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30--100.00%
2025-03-31$42.00K-48.78%
2024-12-31$82.00K95.24%
2024-09-30$42.00K-26.32%
2024-06-30$57.00K100.00%
2024-03-31--100.00%
2023-12-31$4.48M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$14.00K75.00%
2022-09-30$8.00K-81.82%
2022-06-30$44.00K-35.29%
2022-03-31$68.00K-58.79%
2021-12-31$165.00K17.86%
2021-09-30$140.00K28.44%
2021-06-30$109.00K-30.57%
2021-03-31$157.00K-28.96%
2020-12-31$221.00K342.00%
2020-09-30$50.00K-3.85%
2020-06-30$52.00K23.81%
2020-03-31$42.00K-58.82%
2019-12-31$102.00K70.00%
2019-09-30$60.00K-18.92%
2019-06-30$74.00K100.00%
2019-03-31--100.00%
2018-12-31$500.00K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30--

Entera Bio generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Entera Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AGENAgenus$103.46M$30.23M
SPROSpero Therapeutics$47.98M$11.80M
SEERSeer$14.17M$4.12M
IRDOpus Genetics$10.99M-
VTGNVistaGen Therapeutics$1.06M$244.00K
ENTXEntera Bio$181.00K-
MCRBSeres Therapeutics-$351.00K
INOInovio Pharmaceuticals--
ANIXAnixa Biosciences--
ABOSAcumen Pharmaceuticals--
HURATuHURA Biosciences--

ENTX Revenue FAQ

What is Entera Bio’s yearly revenue?

Entera Bio's yearly revenue for 2024 was $181K, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. ENTX's yearly revenue for 2022 was $134K, representing a decrease of -76.53% compared to 2021.

What is Entera Bio’s quarterly revenue?

Entera Bio's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a -100.00% decrease from the previous quarter (Q1 2025), and a -100.00% decrease year-over-year (Q2 2024). ENTX's quarterly revenue for Q1 2025 was $42K, a -48.78% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Entera Bio’s revenue growth rate?

Entera Bio's revenue growth rate for the last 3 years (2022-2024) was 35.07%, and for the last 5 years (2020-2024) was -50.41%.